Association of Grp78, Hif-1Α and Bag3 Expression With the Severity of Chronic Lymphocytic Leukemia

Association of Grp78, Hif-1Α and Bag3 Expression With the Severity of Chronic Lymphocytic Leukemia Publisher Pubmed

Ijabi R¹ ; Roozehdar P² ; Afrisham R³ ; Moradisardareh H³ ; Kaviani S⁴ ; Ijabi J⁵ ; Sahebkar A^{6, 7, 8}

Show Affiliations

1. Faculty of Nursing and Midwifery, Golestan University of Medical Sciences, Shast Kola Road, Gorgan, Iran
2. Department of Medical Veterinary, Azad University, Garmsar Branch, Garmsar, Iran
3. Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
4. Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
5. Faculty of Hematology, School of Allied Health, Iran University of Medical Sciences, Tehran, Iran
6. Halal Research Center of IRI, FDA, Tehran, Iran
7. Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
8. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Source: Anti-Cancer Agents in Medicinal Chemistry Published:2020

Abstract

Introduction: Parallel with the progression of Chronic Lymphocytic Leukemia (CLL), the levels of 78KDa Glucose-Regulated Protein (GRP78) and Hypoxia-Inducible Factor 1 alpha (HIF-1α) are increased as they may activate the induction of anti-apoptotic proteins such as BCL2 Associated Athanogene 3 (BAG3). Previous studies have indicated that there is a positive correlation among GRP78, HIF-1α and BAG3. Objective: This study aimed to evaluate the effect of metabolic factors involved in invasive CLL on apoptotic factors. Methods: A case-control study was conducted on 77 patients diagnosed with CLL along with 100 healthy individuals. Cell blood count was performed for all participants. According to Binet's classification, CLL patients were divided into different groups. B cells were isolated from the peripheral blood of CLL patients by binding to anti-CD19 beads. The expression of BAG3, GRP78 and HIF-1α genes was analyzed using the RT-PCR method. To confirm the results of RT-PCR, western blot analysis was carried out. Results: The results showed that there was a strong association among the expression of BAG3, GRP78 and HIF-1α. The stage of CLL in patients was highly correlated with the expression rate of each gene (p<0.001). Accordingly, the western blot analysis indicated that the concentrations of GRP78 and HIF-1α were significantly higher than the expression of BAG3, considering the stage of CLL. Conclusion: It was shown that increased expression of GRP78 and HIF-1α could result in the elevation of BAG3, as well as the disease progression. Therefore, the role of these metabolic factors might be more pronounced compared with the anti-apoptotic agents to monitor disease progression in CLL patients. © 2020 Bentham Science Publishers.

2. Targeting Hypoxia and Hypoxia-Inducible Factor-1 in the Tumor Microenvironment for Optimal Cancer Immunotherapy, Journal of Cellular Physiology (2022)

3. Identification of Mir-125A As a Novel Plasma Diagnostic Biomarker for Chronic Lymphoblastic Leukemia, Clinical Laboratory (2019)

4. Introduction of a New Recombinant Vaccine Based on Grp78 for Breast Cancer Immunotherapy and Evaluation in a Mouse Model, BioImpacts (2023)

5. Cloning, Prokaryotic Expression, and Functional Characterization of a Novel 70-Kda Heat Shock Protein (Dnak) From Bacillus Persicus, Process Biochemistry (2021)

6. Targeting Perk and Grp78 in Colorectal Cancer: Genetic Insights and Novel Therapeutic Approaches, European Journal of Pharmacology (2024)

Experts (# of related papers)

View all Related Experts

Mohammad Ahmadvand (1)

Zahra Salehi (1)

Style	Citing Format
MLA	Ijabi R, et al.. "Association of Grp78, Hif-1Α and Bag3 Expression With the Severity of Chronic Lymphocytic Leukemia." Anti-Cancer Agents in Medicinal Chemistry, vol. 20, no. 4, 2020, pp. 429-436.
APA	Ijabi R, Roozehdar P, Afrisham R, Moradisardareh H, Kaviani S, Ijabi J, Sahebkar A (2020). Association of Grp78, Hif-1Α and Bag3 Expression With the Severity of Chronic Lymphocytic Leukemia. Anti-Cancer Agents in Medicinal Chemistry, 20(4), 429-436.
Chicago	Ijabi R, Roozehdar P, Afrisham R, Moradisardareh H, Kaviani S, Ijabi J, Sahebkar A. "Association of Grp78, Hif-1Α and Bag3 Expression With the Severity of Chronic Lymphocytic Leukemia." Anti-Cancer Agents in Medicinal Chemistry 20, no. 4 (2020): 429-436.
Harvard	Ijabi R et al. (2020) 'Association of Grp78, Hif-1Α and Bag3 Expression With the Severity of Chronic Lymphocytic Leukemia', Anti-Cancer Agents in Medicinal Chemistry, 20(4), pp. 429-436.
Vancouver	Ijabi R, Roozehdar P, Afrisham R, Moradisardareh H, Kaviani S, Ijabi J, et al.. Association of Grp78, Hif-1Α and Bag3 Expression With the Severity of Chronic Lymphocytic Leukemia. Anti-Cancer Agents in Medicinal Chemistry. 2020;20(4):429-436.
BibTex	@article{ author = {Ijabi R and Roozehdar P and Afrisham R and Moradisardareh H and Kaviani S and Ijabi J and Sahebkar A}, title = {Association of Grp78, Hif-1Α and Bag3 Expression With the Severity of Chronic Lymphocytic Leukemia}, journal = {Anti-Cancer Agents in Medicinal Chemistry}, volume = {20}, number = {4}, pages = {429-436}, year = {2020} }
RIS	TY - JOUR AU - Ijabi R AU - Roozehdar P AU - Afrisham R AU - Moradisardareh H AU - Kaviani S AU - Ijabi J AU - Sahebkar A TI - Association of Grp78, Hif-1Α and Bag3 Expression With the Severity of Chronic Lymphocytic Leukemia JO - Anti-Cancer Agents in Medicinal Chemistry VL - 20 IS - 4 SP - 429 EP - 436 PY - 2020 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract